Roth Affirms Neogen (NEOG) at 'Buy'; Developing Market Efforts Should Outpace FX Issues

Go back to Roth Affirms Neogen (NEOG) at 'Buy'; Developing Market Efforts Should Outpace FX Issues

Neogen Corp (NEOG) Misses Q1 EPS by 2c

September 21, 2015 8:47 AM EDT

Neogen Corp (NASDAQ: NEOG) reported Q1 EPS of $0.25, $0.02 worse than the analyst estimate of $0.27. Revenue for the quarter came in at $74.9 million versus the consensus estimate of $76.35 million.

For earnings history and earnings-related data on Neogen Corp (NEOG) click here.

... More